Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Originally approved by the FDA to manage type 2 diabetes, semaglutide gained widespread attention when clinical trials showed extraordinary results for weight loss leading to FDA approval specifically for chronic weight management under the brand name Wegovy
Semaglutide is a man-made analogue of glucagon-like peptide (GLP-1)
In-person tests require a visit to a Quest Patient Service Center to have a sample taken
In January 2025 Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes who also have chronic kidney disease
US$ 27.52
US$ 23.78
US$ 23.99
US$ 28.40
US$ 29.62
US$ 22.33
US$ 20.87
US$ 22.77
